New Pre-Clinical Studies Demonstrate Cord Blood Stem Cells (CB-SC) Ameliorate the Graft-vs-Host Disease (GvHD) Involved in the Allogeneic Hematopoietic Stem Cell Transplantation
We are pleased to announce that Dr. Yong Zhao collaborated with his colleagues Dr. Robert Korngold’s group at the Center For Discovery and Innovation (CDI) of Hackensack Meridian Health, published
New Studies Revealed the New Molecular Mechanisms Underlying Stem Cell Educator Therapy on Human B Cells
We are happy to announce that Dr. Yong Zhao and his team published a new manuscript that revealed the new molecular mechanisms underlying Stem Cell Educator therapy for the treatment
Holiday Greetings: Happy New Year
Over the last year, Throne has made significant progresses in the FDA-approved clinical trials of Stem Cell Educator therapy for the treatment of type 1 diabetes (T1D), alopecia areata (AA)
Dr. Yong Zhao is invited as Guest Editor for the journal Biomedicines
We are pleased to announce that Dr. Yong Zhao, founder and CEO of Throne Biotechnologies, is invited by an academic journal Biomedicines to edit Special Issue, “Mitochondria in Human Health
Throne Welcomes Renowned Pediatrician, Dr. Richard Fox, as Pediatric Medical Director
Here at Throne Biotechnologies, we are pleased to announce Dr. Richard Fox, M.D., as our Pediatric Medical Director. Dr. Fox received his medical degree from the University of Minnesota in 1975
Revisiting the Pathogenesis of Type 1 Diabetes: Importance of Neural Input to Pancreatic Islets and the Therapeutic Capability of Stem Cell Educator Therapy to Restore Their Integrity
Type 1 diabetes (T1D) is an autoimmune disease with a shortage of islet β cells. To date, the etiology of T1D remains elusive. Increasing clinical evidence and animal studies demonstrate
Throne Starts the US FDA-Approved Clinical Trials of Stem Cell Educator Therapy to Treat Autoimmune Diseases
Throne Biotechnologies (Throne) is a clinical-stage therapeutic company with a disruptive stem cell technology that can fundamentally reverse type 1 diabetes (T1D), alopecia areata (AA) and other autoimmune diseases through
Throne Receives an Award: One of the “2022 Corporate Excellence Awards” by Corporate Vision
We are happy to announce that Throne Biotechnologies (Throne) is an awardee of the “2022’s Most Promising Leaders in Biotechnologies – USA” by Corporate Vision.
Throne Receives an Award: One of the “20 Admired Companies Which Everyone Should Know in 2022” by Global Business Leaders
We are happy to announce that Throne Biotechnologies (Throne) is one of the awardees of the “20 Admired Companies Which Everyone Should Know in 2022″ by Global Business Leaders magazine.
Throne Receives an Award: One of the “20 Most Innovative Companies To Watch in 2022” by Global Radiance Review
We are honored to announce that Throne Biotechnologies (Throne) is one of the awardees of the “20 Most Innovative Companies To Watch in 2022 “ by Global Radiance Review.